Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 346

    Stryker to buy Entellus Medical for 662 million dollars

    Stryker to buy Entellus Medical for 662 million dollars

    Ruby Khatun Khatun9 Dec 2017 10:15 AM IST
    Medical device maker Stryker Corp said on Thursday it would buy Entellus Medical Inc for $662 million, adding heft to its ear, nose, and throat (ENT)...
    More than 2,000 drugs now in cancer immunotherapy race

    More than 2,000 drugs now in cancer immunotherapy race

    Ruby Khatun Khatun9 Dec 2017 10:00 AM IST
    LONDON: The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with...
    Roche drug cocktail doubles chance of holding lung cancer at bay

    Roche drug cocktail doubles chance of holding lung cancer at bay

    Ruby Khatun Khatun9 Dec 2017 9:45 AM IST
    ZURICH: Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease...
    Sage shares surge as depression drug succeeds in mid-stage trial

    Sage shares surge as depression drug succeeds in mid-stage trial

    Ruby Khatun Khatun9 Dec 2017 9:30 AM IST
    Drug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the...
    Lupin, Cadila recall drugs in US Market

    Lupin, Cadila recall drugs in US Market

    Ruby Khatun Khatun8 Dec 2017 11:07 AM IST
    New Delhi: Drug firms Lupin and Cadila Healthcare are recalling nearly 1.11 lakh units of Duloxetine delayed-release capsules and 19,812 bottles of...
    Serum Institute to launch 4 vaccines, enter US, Europe markets

    Serum Institute to launch 4 vaccines, enter US, Europe markets

    Ruby Khatun Khatun8 Dec 2017 10:45 AM IST
    New Delhi: Homegrown global vaccines major Serum Institute of India plans to launch at least four products and enter European and US markets in the...
    Merck get approval for Mavenclad to treat relapsing-remitting multiple sclerosis in Canada

    Merck get approval for Mavenclad to treat relapsing-remitting multiple sclerosis in Canada

    Ruby Khatun Khatun8 Dec 2017 9:47 AM IST
    DARMSTADT, Germany: Merck announced that Health Canada has approved MAVENCLAD™ (Cladribine Tablets) as monotherapy for the treatment of adult patients...
    Bayer, Johnson and Johnson to pay 28 million dollars in Xarelto lawsuit

    Bayer, Johnson and Johnson to pay 28 million dollars in Xarelto lawsuit

    Ruby Khatun Khatun8 Dec 2017 9:32 AM IST
    A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers’...
    Shire in deal to develop a new way to administer hemophilia drug

    Shire in deal to develop a new way to administer hemophilia drug

    Ruby Khatun Khatun8 Dec 2017 9:15 AM IST
    Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.The...
    India and Cuba sign MoU for pharma regulation, medical devices

    India and Cuba sign MoU for pharma regulation, medical devices

    Ruby Khatun Khatun7 Dec 2017 11:00 AM IST
    New Delhi: India and Cuba inked a MoU for enhanced cooperation in the health sector by pooling in technical, scientific, financial and human...
    Shalby IPO subscribed 46 percent as on Day 2

    Shalby IPO subscribed 46 percent as on Day 2

    Ruby Khatun Khatun7 Dec 2017 10:45 AM IST
    New Delhi: The initial public offer of Shalby Ltd, the Ahmedabad-based multi-specialty hospital chain, was subscribed 46 per cent as on the second day...
    Philippines halts sale of dengue vaccine, WHO backs decision

    Philippines halts sale of dengue vaccine, WHO backs decision

    Ruby Khatun Khatun7 Dec 2017 10:30 AM IST
    MANILA/LONDON: The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution, and marketing of its Dengvaxia dengue vaccine in...
    PrevNext

    Popular Stories

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    KKRs Envision Healthcare hires bank to explore debt restructuring: Report

    KKR's Envision Healthcare hires bank to explore debt restructuring: Report

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok